COMMUNIQUÉS West-GlobeNewswire

BIOPHYTIS to Host Key Opinion Leader Meeting on the Biology of Aging and its Application in Neuromuscular Diseases
27/11/2018
PARIS, Nov. 27, 2018 (GLOBE NEWSWIRE) -- Biophytis (Euronext Growth Paris: ALBPS), a clinical-stage biotechnology company specializing in the development of drug candidates to treat the disabilities caused by age- [...]
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 octobre 2018
27/11/2018
Communiqué de presse Villepinte, le 27 novembre 2018 DECLARATION RELATIVE AU NOMBRE DE DROITS DE VOTE ET D'ACTIONS COMPOSANT LE CAPITAL DE LA SOCIETE En application de l'article L. 233-8 II du code de commerce et de l' [...]
Shire plc: JAMA Publishes Complete Results of Phase 3 HELP Study™ Evaluating Lanadelumab as a Preventive Treatment for Hereditary Angioedema
27/11/2018
Intended for Global Audience JAMA Publishes Complete Results of Phase 3 HELP Study™ Evaluating Lanadelumab as a Preventive Treatment for Hereditary Angioedema Lanadelumab is a first-of-its kind monoclonal antibody [...]
Helsinn and Lyfebulb Announce Partnership for Second Annual Patient-Driven Innovation Summit in Cancer
27/11/2018
The award will be presented to the Patient Entrepreneur demonstrating outstanding science and potential to bring their idea to the market for cancer patients LUGANO, SWITZERLAND, AND NEW YORK, NY, November 27, 2018: [...]
Antares Pharma Partner Teva Announces Commercial Availability of Generic Epipen®
27/11/2018
Teva’s Epinephrine Auto Injector Product FDA Approved as Therapeutically Equivalent and Fully Substitutable at the Pharmacy EWING, N.J., Nov. 27, 2018 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (“Antares”) [...]
MedMira Inc. Announces Appointment of Auditor and Late Filing of Annual Financial Statements
27/11/2018
DEFAULT NOTICE HALIFAX, Nova Scotia, Nov. 27, 2018 (GLOBE NEWSWIRE) -- MedMira Inc. (TSXV: MIR) (“MedMira” or the “Company”) announced today that it has engaged Arsenault Best Cameron Ellis of Charlottetown, Prince [...]
Syneos Health Releases the 2019 Health Trend Ten, Outlining Critical Shifts Impacting Drug Development and Commercialization
27/11/2018
eBook Provides Biopharma Decision Makers With What’s-Next Insights to Navigate Challenges and Capitalize on the Opportunities Ahead RALEIGH, N.C., Nov. 27, 2018 (GLOBE NEWSWIRE) -- Syneos Health™ (Nasdaq:SYNH), the only [...]
PRA Health Sciences Launches Pediatric Site Network
27/11/2018
RALEIGH, N.C., Nov. 27, 2018 (GLOBE NEWSWIRE) -- PRA Health Sciences (PRA) is pleased to announce the launch of its new Pediatric Site Network (PSN). PSN is a series of key pediatric research centers around the world [...]
Tabula Rasa HealthCare to Host Investor and Analyst Day on December 4, 2018
27/11/2018
MOORESTOWN, N.J, Nov. 27, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ:TRHC), a healthcare technology company advancing the field of medication safety, today announced it will host its [...]
Scapa Healthcare Introduces Hydrocolloid Offering for Cold Sore Treatment
27/11/2018
Discreet OTC Patches to Conceal & Prevent the Spread of the HSV-1 Virus WINDSOR, Conn., Nov. 27, 2018 (GLOBE NEWSWIRE) -- Scapa Healthcare , a global strategic outsource partner of skin friendly turn-key solutions, [...]
Nelipak Healthcare Packaging Expands Operations in Humacao, Puerto Rico
27/11/2018
CRANSTON, R.I., Nov. 27, 2018 (GLOBE NEWSWIRE) -- Nelipak ® Healthcare Packaging (“Nelipak”), a full-service global provider of custom thermoformed packaging that provides superior protection for medical devices and [...]
Precipio ICE COLD-PCR™ Technology Selected by the University of Cincinnati Medical Center for Liquid Biopsy Study
27/11/2018
Research Study to Focus on Screening for Actionable Mutations in Non-Small Cell Lung Cancer NEW HAVEN, Conn., Nov. 27, 2018 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. ( NASDAQ: PRPO ) [...]
AroCell presents results from the U-CAN TK1 lymphoma study and from a comparison study between TK 210™ ELISA and other assays
27/11/2018
AroCell’s Chief Scientific Officer, Professor Staffan Eriksson, presents today new preliminary results from the U-CAN TK1 lymphoma study at the International Society of Oncology Biomarkers (ISOBM) in Hamburg. The [...]
MannKind Appoints Christine Mundkur to its Board of Directors
27/11/2018
WESTLAKE VILLAGE, Calif., Nov. 27, 2018 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) today announced that Christine Mundkur has joined its Board of Directors, effective November 27, 2018. Ms. Mundkur will [...]
Raleigh Radiology selects Client Outlook as Vendor of Choice for Integrated Clinical and Diagnostic Viewing
27/11/2018
WATERLOO, Ontario, Nov. 27, 2018 (GLOBE NEWSWIRE) -- Client Outlook, a leading provider of FDA Class II enterprise diagnostic and clinical image viewing solutions, announced today it has been selected as the vendor of [...]
Altimmune Appoints Vipin K. Garg, Ph.D. as its New President and Chief Executive Officer
27/11/2018
GAITHERSBURG, Md., Nov. 27, 2018 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage immunotherapeutics company, today announced the appointment of Vipin K. Garg, Ph.D. as its President and Chief [...]
Predictive Technology Group to Present at 11th Annual LD Micro Main Event Conference on December 4
27/11/2018
SALT LAKE CITY, Nov. 27, 2018 (GLOBE NEWSWIRE) -- Predictive Technology Group, Inc. (OTC/PINK: PRED), a life-sciences technology company, announces that Bradley Robinson, President and CEO, will present a corporate [...]
OrthoPediatrics Corp. Enhances Product Offering with Upgraded PediLoc® Femur Plate System
27/11/2018
WARSAW, Ind., Nov. 27, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, announced today the U.S. launch of its new PediLoc® [...]
Medibio Signs Insurance Company AIA Australia Ltd (AIAA) For an Exclusive Pilot Program For ilumen™
27/11/2018
SYDNEY, Australia and MINNEAPOLIS, Nov. 27, 2018 (GLOBE NEWSWIRE) -- Medibio Limited ( MEB or the Company )(ASX: MEB)(OTCQB: MDBIF), a mental health technology company announces that it has signed an exclusive agreement [...]

Pages